5,600
Participants
Start Date
May 10, 2021
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2028
DOvEEgene test
Women participating in the study will undergo a genomic uterine pap test, DOvEEgene test, for the screening of ovarian and endometrial cancers. Clinical tests will also be administered as a comparator (CA-125 blood test and TVUS).
RECRUITING
McGill University Health Centre, Royal Victoria Hospital, Montreal
RECRUITING
Queen Elizabeth Health Complex, Montreal
Genome Canada
OTHER
Genome Quebec
OTHER
Research Institute of the McGill University Health Center
UNKNOWN
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
McGill University
OTHER